News
Pharma firms will face 15% tariffs in Trump’s E.U. trade deal
WASHINGTON — President Trump’s tariffs on pharmaceuticals coming from the European Union will be set at 15% and will not go into effect until a national security investigation has been completed, according to a White House official familiar with the plans.
50% to 200%: Trump’s tariffs on copper and pharma could hurt India the most due to…, companies likely to be affected are…
Trump announced significant increases to import tariffs: a 50% tariff on copper and a planned 200% tariff on pharmaceuticals, the latter to take effect after a one-year delay.
Americans cannot absorb billions in added drug price hikes as a result of ill-designed and poorly timed tariff increases.
AMERICAN patients will pay the cost of Donald Trump’s 15 per cent tariffs on Europe’s pharmaceutical industry, an Irish ...
An EU pharma lobby has criticized the Trump administration’s plans to impose 15% tariffs on pharmaceutical imports amid uncertainty over how the newly announced U.S.-EU trade deal targets the product ...
Pharmaceutical tariffs are coming, part of President Trump’s stated goal of bringing drug manufacturing back to the U.S.
Hosted on MSN22d
Trump says he will impose 50% tariff on copper imports
He did not say specifically when that tariff would take effect. Trump also said he would soon announce tariffs "at a very, very high rate, like 200%," on pharmaceutical imports.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback